We Harness Nature’s Most Powerful Weapons to Fight Cancer:
The Human Immune System & Radiation
Relevant Bio - Cancer therapeutic breakthroughs optimized naturally by human biology
We are a pioneering biotech company specializing in the development of Radiotheranostics for the treatment of cancer. Our innovative approach leverages native human antibodies, optimized based on their size, to serve as ideal carriers for delivering radioisotopes.
Our unique method allows us to confirm the presence of disease through imaging, while simultaneously delivering therapeutic doses of radiation to specifically target and kill cancer cells. This precision based approach significantly reduces the toxicity often associated with other theranostic competitors and traditional cancer therapies, including external beam radiation.
Find out more about our Company, Science, Pipeline and Partnering Opportunities by exploring below:
Dive into the heart of our organization and discover an in-depth look at our history, mission, values, and the dedicated team that drives our success.
Leveraging modern medical advancements, our approach combines the innate power of human biology with state-of-the-art technology, ensuring a synergistic and highly effective strategy in the battle against cancer.
We have screened over 16 million memory B-cells to identify and clone five high-affinity antibodies that target clinically validated key immune checkpoints and tumor associated antigens.
Join us in advancing a new era of cancer care grounded in the brilliance of nature.